Scholar Rock(SRRK)盘初暴涨31.12% 竞争对手公司脊髓性肌肉萎缩症药物研究未达预期

金吾财讯
25 Nov 2024

金吾财讯 | Scholar Rock(SRRK)盘初急升,截止发稿,涨31.12%,报39.23美元,成交额6181.45万美元。

消息面上,竞争对手生物制药公司biohaven(BHVN)表示,其针对脊髓性肌肉萎缩症的实验药物的研究在48周内与安慰剂和标准护理相比没有达到"统计学显著差异"。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10